BPG is committed to discovery and dissemination of knowledge
Topic Highlight
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 15965-15974
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.15965
Table 1 End-points generally evaluated to assess treatment efficacy
RVRUndetectable serum hepatitis C virus (HCV) RNA after 4 wk of treatment
EVRUndetectable or at least a 2 log decrease in serum HCV RNA from baseline level after 12 wk of treatment
End-of-treatment responseUndetectable serum HCV RNA at the conclusion of treatment
SVRUndetectable serum HCV RNA 24 wk after the end of treatment
Non-responseDetectable serum HCV RNA at 24 wk of treatment without any significant decrease in serum HCV RNA level
RelapseDetection of serum HCV RNA after SVR had been achieved


Write to the Help Desk